Although the U.S. government puts stringent restrictions on funding for research on embryonic stem cells, individual states such as California have set up institutes to perform that work and
general stem cell studies.
Not exact matches
In a
study recently published in the journal Nature Biotechnology, HSCI researchers at Harvard University and Massachusetts
General Hospital (MGH), in collaboration with Boston Children's Hospital and Dana Farber Cancer Institute, have developed a non-toxic transplantation procedure using antibodies to specifically target blood
stem cells in mice, an approach they hope will make blood
stem cell transplants for these patients far less toxic.
Co-authors on the
study were Christian Mosimann (University of Zürich), Zi Peng Fan (Whitehead Institute and MIT), Justin Tan (Genome Institute of Singapore), Richard White (Memorial Sloan Kettering Cancer Center), Dominick Matos (Massachusetts
General Hospital), Ann - Christin Puller (University Medical Center Hamburg - Eppendorf, Germany), Eric Liao (Harvard
Stem Cell Institute and MGH) Richard Young (Whitehead Institute and MIT), and, at Boston Children's Hospital, Song Yang, Andrew Thomas, Julien Ablain, Rachel Fogley, Ellen van Rooijen, Elliott Hagedorn, Christie Ciarlo and Cristina Santoriello.
Now, in a new
study in
Cell Stem Cell, the group have begun to delineate the mechanisms controlling organ bud formation, and from these findings they have been able to describe a general methodology for the formation of large vascularized, complex organ buds from diverse organs using specific stem cell combinations
Cell Stem Cell, the group have begun to delineate the mechanisms controlling organ bud formation, and from these findings they have been able to describe a general methodology for the formation of large vascularized, complex organ buds from diverse organs using specific stem cell combinations
Stem Cell, the group have begun to delineate the mechanisms controlling organ bud formation, and from these findings they have been able to describe a general methodology for the formation of large vascularized, complex organ buds from diverse organs using specific stem cell combinations
Cell, the group have begun to delineate the mechanisms controlling organ bud formation, and from these findings they have been able to describe a
general methodology for the formation of large vascularized, complex organ buds from diverse organs using specific
stem cell combinations
stem cell combinations
cell combinations [4].
This two - volume reference integrates this exciting area of biology, combining the prerequisites for a
general understanding of adult and embryonic
stem cells, the tools, methods, and experimental protocols needed to
study and characterize
stem cells and progenitor populations, as well as a presentation by the world's experts of what is currently known about each specific organ system.
Although no
studies have directly confirmed its effect on breast cancer
stem cells thus far, the outlook is positive that one day the connection may be made considering its cytotoxic effect on breast cancer
cells, in
general, has already proven to be so high.
The
study also identified a potentially useful biomarker that could determine if cats will respond to
stem cell treatment in
general (as not all do).
There are
studies showing vast improvements with
stem cell treatments and many
general practitioners are now providing this therapy in - house.